Ester Sklarsky joins Sound Bioventures

Today we welcome Ester Sklarsky to the Sound Bioventures investment team as an Associate. Ester will manage our dealflow, identify new investment opportunities and conduct scientific and commercial due diligence.

Ester joins us from Industrifonden where she made life science venture capital investments as an analyst as well as an associate. Ester also has prior experience as a management consultant at Sirona Health Solutions, where she worked with key stakeholders in the Swedish public healthcare sector, as well as as an equity analyst at the bank DNB, where she focused on the Biotech sector.

Ester holds a bachelor’s degree in Biomedicine from the Karolinska Institute and a master’s degree in Bioentrepreneurship, also fromthe  Karolinska Institute.

Ester will be based at the Stockholm, SE, office.

Artax Biopharma Expands Company’s Scientific Advisory Board and Welcomes James G. Krueger, M.D., Ph.D., and Ajay Nirula, M.D., Ph.D., Both Experts in T-Cell-Mediated Diseases

Cambridge, MA, November 15, 2022 Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T-cell-mediated diseases, today announces the Company is strengthening its Scientific Advisory Board (SAB) with the appointments of James G. Krueger, M.D., Ph.D., and Ajay Nirula, M.D., Ph.D. Artax Biopharma has an ...